Mucosal Leishmaniasis Due to Leishmania (Viannia) Braziliensis L(V)b in Três Braços, Bahia-Brazil
Overview
Authors
Affiliations
Brazilian mucosal leishmaniasis is briefly reviewed, emphasis being given to recent advances clinical management. Patients continue to occupy much hospital bed space and in some cases are notoriously difficult to treat. Indefinite follow up is recommended. Many aspects of the aetiology remain mysterious although Leishmania (Viannia) braziliensis is the most common organism isolated. Perspectives for a more effective treatment, oral and cheap, are still remote.
High Anti- IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.
De Lima C, Magalhaes A, Costa R, Barreto C, Machado P, Carvalho E Front Cell Infect Microbiol. 2021; 11:652956.
PMID: 33898330 PMC: 8063102. DOI: 10.3389/fcimb.2021.652956.
Tegegne B, Alemu G Int Med Case Rep J. 2020; 13:551-555.
PMID: 33116948 PMC: 7585787. DOI: 10.2147/IMCRJ.S275133.
Mucocutaneous Leishmaniasis with Rare Manifestation in the Nasal Mucosa and Cartilage Bone Septal.
Casalle N, de Barros Pinto Grifoni L, Bosco Mendes A, Delort S, Massucato E Case Rep Infect Dis. 2020; 2020:8876020.
PMID: 33029438 PMC: 7528117. DOI: 10.1155/2020/8876020.
Interventions for American cutaneous and mucocutaneous leishmaniasis.
Pinart M, Rueda J, Romero G, Pinzon-Florez C, Osorio-Arango K, Maia-Elkhoury A Cochrane Database Syst Rev. 2020; 8:CD004834.
PMID: 32853410 PMC: 8094931. DOI: 10.1002/14651858.CD004834.pub3.
Silva S, Guimaraes L, Silva J, Magalhaes V, Medina L, Queiroz A Acta Trop. 2017; 178:34-39.
PMID: 29042262 PMC: 5748360. DOI: 10.1016/j.actatropica.2017.10.010.